Porcine and Rangiferine Brucellosis: Brucella Suis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Brucellosis Tip Sheet June 2018
BRUCELLOSIS Background Brucellosis is an infectious disease caused by Brucella species such as Brucella melitensis, Brucella abortus, and Brucella suis. People can get the disease when they are in contact with infected animals or animal products contaminated with the bacteria. From 1993 through 2010, the number of brucellosis cases reported in the US ranged from 79 to 139, with an average of 109 cases per year. In 2010, the highest number (56.5%) of brucellosis cases was reported by California, Texas, Arizona, and Florida. Michigan reported four cases that same year (range=0‐10 cases per year). Signs and Symptoms Acute Non‐specific: fever, sweats, malaise, anorexia, headache, pain in muscles, joint, and/or back pain, fatigue Sub‐clinical infections are common Lymphadenopathy (10–20%), splenomegaly (20–30%) Chronic Recurrent fever Arthritis and spondylitis Swelling of the testicle and scrotum area Swelling of the heart (endocarditis) Swelling of the liver and/or spleen Neurologic symptoms (in up to 5% of all cases) Possible focal organ involvement Chronic fatigue Depression Brucellosis in Pregnant Women Brucellosis during pregnancy carries the risk of causing spontaneous abortion, particularly during the first and second trimesters; therefore, women should receive prompt medical treatment with the proper antimicrobials. Incubation Period Highly variable (5 days–6 months) Average onset 2–4 weeks Transmission Ingestion: The most common way to be infected is by eating or drinking unpasteurized/raw dairy products. When sheep, goats, cows, or camels are infected, their milk becomes contaminated with the bacteria. If milk from infected animals is not pasteurized, the infection will be transmitted to people who consume the milk and/or cheese products. -
Recent Advances in Understanding Immunity Against Brucellosis: Application for Vaccine Development
The Open Veterinary Science Journal, 2010, 4, 101-107 101 Open Access Recent Advances in Understanding Immunity Against Brucellosis: Application for Vaccine Development Sérgio Costa Oliveira*,1, Gilson Costa Macedo1, Leonardo Augusto de Almeida1, Fernanda Souza de Oliveira1, Angel Onãte2, Juliana Cassataro3 and 3 Guillermo Hernán Giambartolomei 1Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte-Minas Gerais, Brazil 2Department of Microbiology, Faculty of Biological Sciences, Molecular Immunology Laboratory, Universidad de Concepción, Concepción, Chile 3Instituto de Estudios de la Inmunidad Humoral (CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires (UBA), Buenos Aires, Argentina Abstract: Brucellosis is an important zoonotic disease of nearly worldwide distribution. This pathogen causes abortion in cattle and undulant fever, arthritis, endocarditis and meningitis in human. The immune response against B. abortus involves innate and adaptive immunity involving antigen-presenting cells, NK cells and CD4+ and CD8+ T cells. IFN- is a crucial immune component that results from Brucella recognition by host immune receptors such as Toll-like receptors (TLRs) that lead to IL-12 production. Although great efforts to elucidate immunity against Brucella have been employed, the subset of cells and factors involved in host immune response remains not completely understood. Our group and others have been working in an attempt to understand the mechanisms involved in innate responses to Brucella. Understanding the requirements for immune protection can help the design of alternative vaccines that would avoid the drawbacks of currently available vaccines to Brucella. This review discusses recent studies in host immunity to Brucella and new approaches for vaccine development. -
Genital Brucella Suis Biovar 2 Infection of Wild Boar (Sus Scrofa) Hunted in Tuscany (Italy)
microorganisms Article Genital Brucella suis Biovar 2 Infection of Wild Boar (Sus scrofa) Hunted in Tuscany (Italy) Giovanni Cilia * , Filippo Fratini , Barbara Turchi, Marta Angelini, Domenico Cerri and Fabrizio Bertelloni Department of Veterinary Science, University of Pisa, Viale delle Piagge 2, 56124 Pisa, Italy; fi[email protected] (F.F.); [email protected] (B.T.); [email protected] (M.A.); [email protected] (D.C.); [email protected] (F.B.) * Correspondence: [email protected] Abstract: Brucellosis is a zoonosis caused by different Brucella species. Wild boar (Sus scrofa) could be infected by some species and represents an important reservoir, especially for B. suis biovar 2. This study aimed to investigate the prevalence of Brucella spp. by serological and molecular assays in wild boar hunted in Tuscany (Italy) during two hunting seasons. From 287 animals, sera, lymph nodes, livers, spleens, and reproductive system organs were collected. Within sera, 16 (5.74%) were positive to both rose bengal test (RBT) and complement fixation test (CFT), with titres ranging from 1:4 to 1:16 (corresponding to 20 and 80 ICFTU/mL, respectively). Brucella spp. DNA was detected in four lymph nodes (1.40%), five epididymides (1.74%), and one fetus pool (2.22%). All positive PCR samples belonged to Brucella suis biovar 2. The results of this investigation confirmed that wild boar represents a host for B. suis biovar. 2 and plays an important role in the epidemiology of brucellosis in central Italy. Additionally, epididymis localization confirms the possible venereal transmission. Citation: Cilia, G.; Fratini, F.; Turchi, B.; Angelini, M.; Cerri, D.; Bertelloni, Keywords: Brucella suis biovar 2; wild boar; surveillance; epidemiology; reproductive system F. -
Acute Brucella Melitensis M16 Infection Model in Mice Treated with Tumor Necrosis Factor-Alpha Inhibitors
Original Article Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors Murat Kutlu1, Çağrı Ergin2, Nilay Şen-Türk3, Selda Sayin-Kutlu1, Orçun Zorbozan2, Şerife Akalın1, Barboros Şahin4, Veli Çobankara5, Neşe Demirkan3 1 Department of Infectious Diseases and Clinical Microbiology, Pamukkale University, Faculty of Medicine, Denizli, Turkey 2 Department of Medical Microbiology, Pamukkale University, Faculty of Medicine, Denizli, Turkey 3 Department of Pathology, Pamukkale University, Faculty of Medicine, Denizli, Turkey 4 Animal Research Laboratory, Pamukkale University, Denizli, Turkey 5 Department of Internal Medicine, Section of Rheumatology, Pamukkale University, Faculty of Medicine, Denizli, Turkey Abstract Introduction: There is limited data in the literature about brucellosis related to an intracellular pathogen and anti-tumor necrosis factor alpha (anti-TNFα) medication. The aim of this study was to evaluate acute Brucella infections in mice receiving anti-TNFα drug treatment. Methodology: Anti-TNFα drugs were injected in mice on the first and fifth days of the study, after which the mice were infected with B. melitensis M16 strain. Mice were sacrificed on the fourteenth day after infection. Bacterial loads in the liver and spleen were defined, and histopathological changes were evaluated. Results: Neither the liver nor the spleen showed an increased bacterial load in all anti-TNFα drug groups when compared to a non-treated, infected group. The most significant histopathological findings were neutrophil infiltrations in the red pulp of the spleen and apoptotic cells with hepatocellular pleomorphism in the liver. There was no significant difference among the groups in terms of previously reported histopathological findings, such as extramedullary hematopoiesis and granuloma formation. -
A Small Non-Coding RNA Facilitates Brucella Melitensis Intracellular Survival by Regulating the Expression of Virulence Factor T
International Journal of Medical Microbiology 309 (2019) 225–231 Contents lists available at ScienceDirect International Journal of Medical Microbiology journal homepage: www.elsevier.com/locate/ijmm A small non-coding RNA facilitates Brucella melitensis intracellular survival by regulating the expression of virulence factor T Yufei Wanga,1, Yuehua Keb,1, Cuijuan Duana,1, Xueping Maa, Qinfang Haoa, Lijie Songa, ⁎⁎⁎ Xiaojin Guoa, Tao Suna, Wei Zhanga, Jing Zhanga, Yiwen Zhaoa, Zhijun Zhongc, , ⁎⁎ ⁎ Xiaoli Yanga, , Zeliang Chenb,d, a Department of laboratory medicine, The Third Medical Center, General Hospital of the Chinese People’s Liberation Army, Beijing 100039, China b Department of Infectious Disease Control, Center of Disease Control and Prevention, Beijing 100071, China c Key Laboratory of Animal Disease and Human Health of Sichuan Province, College of Veterinary Medicine, Sichuan Agricultural University, Sichuan 611130, China d Key Laboratory of Livestock Infectious Diseases in Northeast China, Ministry of Education, Key Laboratory of Zoonosis of Liaoning Province, College of Aninal Science and Veterinary Medicine, Shenyang Agricultural University, Liaoning, 110866, China ARTICLE INFO ABSTRACT Keywords: Brucella species are the causative agents of brucellosis, a worldwide zoonotic disease that affects a broad range of Brucella mammals and causes great economic losses. Small regulatory RNAs (sRNAs) are post-transcriptional regulatory sRNA molecules that participate in the stress adaptation and pathogenesis of Brucella. In this study, we characterized Intracellular survival the role of a novel sRNA, BSR1141, in the intracellular survival and virulence of Brucella melitensis. The results Stress response show that BSR1141 was highly induced during host infections and under in vitro stress situations that simulated Virulence the conditions encountered within host phagocytes. -
Brucellosis Reporting and Investigation Guideline
Brucellosis Signs and • Acute or insidious irregular fevers, sweats, chills, headache, anorexia, arthralgia Symptoms • Can be hepatic or splenic abscesses, or osteoarticular or genitourinary symptoms • Chronic infections may cause arthritis, osteomyelitis, endocarditis, or neurological complications Incubation Typically 2-4 weeks (range 5 days-5 months) Case Clinical criteria: fever and one or more of the following: night sweats, fatigue, classification anorexia, myalgia, weight loss, headache, arthralgia, arthritis/spondylitis, meningitis, or focal organ involvement (heart, testes, liver, spleen) Confirmed: Clinically consistent with Probable: Clinically consistent with epi link positive culture or 4-fold rise in titers to human or animal case or titer by taken at least 2 weeks apart agglutination ≥ 160 or PCR positive Differential Includes multiple causes of fever including bacterial endocarditis, viral hepatitis, diagnosis leptospirosis, lymphoma, malaria, rickettsioses, tuberculosis, toxoplasmosis, tularemia, typhoid, vasculitis Treatment Appropriate antibiotic combination (generally dual therapy) for weeks. Rare deaths from endocarditis. Duration Acute illness days to week, chronic infection months to years Exposure Skin or mucosal membrane exposure to infected birth tissues or fluids from cattle, goats, sheep, elk, deer; consuming raw milk from infected animal; inhalational exposure in a laboratory or slaughterhouse; potential agent of bioterrorism; rare transmission sexually or through breast milk Laboratory Local Health Jurisdiction -
Brucellosis Annual Report 2018
Brucellosis Annual Report 2018 Brucellosis Brucellosis is a Class A Disease. It must be reported to the state within 24 hours by calling the number listed on the website. Brucellosis is a zoonotic infection of domesticated and wild animals, caused by bacteria of the genus Brucella. Humans become infected by ingestion of food products of animal origin (such as undercooked meat or unpasteurized milk or dairy products), direct contact with infected animals, or inhalation of infectious aerosols. Brucella abortus (cattle), B.melitensis (sheep and goats), B.suis (pigs), and B.canis (dogs), are the most common species. The most common etiology in the U.S. is B.melitensis. Marine Brucella (B.ceti and B.pinnipedialis) may also pose a risk to humans who interact with marine animals; people should avoid contact with stranded or dead marine mammals. Infection may cause a range of symptoms, including fever, sweats, malaise, anorexia, headache, joint and muscle pain, and fatigue. Some symptoms may last for prolonged periods of time including recurrent fevers, arthritis, swelling of the testicle and scrotum area, swelling of the heart, swelling of the liver and/or spleen, neurologic symptoms, chronic fatigue, and depression. Treatment consists of antibiotics, but recovery may take a few weeks to several months. Bovine brucellosis caused by B. abortus, is a bacterial infection transmitted through oral exposure to uterine discharges from infected cows at time of calving or abortion. This previously common disease has been eliminated from the state through the cooperation of the cattle industry and state-federal animal health officials. On November 1, 2000, Louisiana was declared free of brucellosis in cattle. -
Brucellosis History Summary by Russell W
Brucellosis History Summary by Russell W. Currier DVM, MPH Dr. Currier is a DVM, MPH, and Diplomate of the American College for Veterinary Preventive Medicine, who retired from a career as an Iowa State Public Health Veterinarian. Dr. Currier currently presides as President of the American Veterinary Medical History Society. Brucellosis is a sexually transmissible as well as contact-transmitted infection of livestock that can have adverse effects on the fetus and newborn. It occasionally transmits to humans in roles of animal handlers, raw milk consumers, and packing plant workers. In humans, the disease is infectious with long term chronic but distressing febrile episodes rarely fatal with modern clinical management; treatment remains in the domain of infectious disease physicians and should not be attempted by family doctors. The causative organism is Brucella melitensis [from sheep/goats], Brucella bovis [from cattle], Brucella suis [from swine] and Brucella canis [from dogs]. Historically, the disease was recognized in the Mediterranean region, particularly in goats and sheep, dating back to antiquity. Brucellosis-type illnesses were recognized by Hippocrates in his Epidemics writings; the Apostle Paul is considered to have been infected following his being shipwrecked on the Island of Malta and suffered from a recurrent illness or “thorn in my flesh” afterward. Britain maintained a military base on this island during the 18th and 19th centuries. During this period, several British physicians provided vivid descriptions of illness in garrisoned troops and physician David Bruce was dispatched to investigate; he isolated the causative organism from four fatal cases in 1887 and named it Micrococcus melitensis. -
The Acidic Stress Response of the Intracellular Pathogen Brucella Melitensis: New Insights from a Comparative, Genome-Wide Transcriptome Analysis
G C A T T A C G G C A T genes Article The Acidic Stress Response of the Intracellular Pathogen Brucella melitensis: New Insights from a Comparative, Genome-Wide Transcriptome Analysis David Kornspan 1,*, Tamar Zahavi 2 and Mali Salmon-Divon 2,3 1 Department of Bacteriology, Kimron Veterinary Institute, Bet Dagan 50250, Israel 2 Genomic Bioinformatics Laboratory, Department of Molecular Biology, Ariel University, Ariel 40700, Israel; [email protected] (T.Z.); [email protected] (M.S.-D.) 3 Adelson School of Medicine, Ariel University, Ariel 40700, Israel * Correspondence: [email protected]; Tel.: +972-3-968-1745 Received: 14 July 2020; Accepted: 25 August 2020; Published: 28 August 2020 Abstract: The intracellular pathogenic bacteria belonging to the genus Brucella must cope with acidic stress as they penetrate the host via the gastrointestinal route, and again during the initial stages of intracellular infection. A transcription-level regulation has been proposed to explain this but the specific molecular mechanisms are yet to be determined. We recently reported a comparative transcriptomic analysis of the attenuated vaccine Brucella melitensis strain Rev.1 against the virulent strain 16M in cultures grown under either neutral or acidic conditions. Here, we re-analyze the RNA-seq data of 16M from our previous study and compare it to published transcriptomic data of this strain from both an in cellulo and an in vivo model. We identify 588 genes that are exclusively differentially expressed in 16M grown under acidic versus neutral pH conditions, including 286 upregulated genes and 302 downregulated genes that are not differentially expressed in either the in cellulo or the in vivo model. -
Genome-Resolved Metagenomic Analyses Reveal the Presence of a Putative Bacterial Endosymbiont in an Avian Nasal Mite (Rhinonyssidae; Mesostigmata)
microorganisms Article Genome-Resolved Metagenomic Analyses Reveal the Presence of a Putative Bacterial Endosymbiont in an Avian Nasal Mite (Rhinonyssidae; Mesostigmata) Carolina Osuna-Mascaró 1,*, Jorge Doña 2,3, Kevin P. Johnson 2 and Manuel de Rojas 4,* 1 Department of Biology, University of Nevada, 1664 N Virginia St., Reno, NV 89557, USA 2 Illinois Natural History Survey, Prairie Research Institute, University of Illinois at Urbana-Champaign, Champaign, IL 61820, USA; [email protected] (J.D.); [email protected] (K.P.J.) 3 Departamento de Biología Animal, Universitario de Cartuja, Calle Prof. Vicente Callao, 3, 18011 Granada, Spain 4 Department of Microbiology and Parasitology, Faculty of Pharmacy, Universidad de Sevilla, Calle San Fernando, 4, 41004 Sevilla, Spain * Correspondence: [email protected] (C.O.-M.); [email protected] (M.d.R.) Abstract: Rhinonyssidae (Mesostigmata) is a family of nasal mites only found in birds. All species are hematophagous endoparasites, which may damage the nasal cavities of birds, and also could be potential reservoirs or vectors of other infections. However, the role of members of Rhinonyssidae as disease vectors in wild bird populations remains uninvestigated, with studies of the microbiomes of Rhinonyssidae being almost non-existent. In the nasal mite (Tinaminyssus melloi) from rock doves (Columba livia), a previous study found evidence of a highly abundant putatively endosymbiotic bacteria from Class Alphaproteobacteria. Here, we expanded the sample size of this species (two Citation: Osuna-Mascaró, C.; Doña, different hosts- ten nasal mites from two independent samples per host), incorporated contamination J.; Johnson, K.P.; de Rojas, M. Genome-Resolved Metagenomic controls, and increased sequencing depth in shotgun sequencing and genome-resolved metagenomic Analyses Reveal the Presence of a analyses. -
Canine Brucellosis Information for Dog Owners
Canine Brucellosis Information for Dog Owners Key Facts Canine brucellosis is found world-wide. It is an increasing concern in North America due to importation of infected breeding dogs and semen for artificial insemination. Disease in dogs can be: • Subclinical, dogs frequently have no obvious disease signs. • Associated with acute or chronic signs, such as: o Reproductive disease, e.g. abortion (typically late term), weak pups who die shortly after birth, infertility (bitch or stud) o Spine or neurologic disease, e.g. back or neck pain Infection is poorly responsive to treatment. Breeding programs with infertility or abortion concerns should promptly test dogs. All breeding programs should have a routine testing schedule, especially for any new dogs. Brucellosis is a zoonotic disease. Infected dogs can infect people and in many jurisdictions it is reportable to animal and public health agencies. What is it? Brucellosis is due to infection with the Brucella bacterium. Brucella canis is the most common species found in dogs. It is most often transmitted through direct dog-to-dog contact via infected body fluids and tissues (e.g. vaginal discharge, aborted fetus, placenta, semen, urine). Other Brucella spp. can also infect dogs (including Brucella abortus and Brucella suis) after dogs consume placenta, aborted fetuses, or uncooked meat from infected livestock or have contact with wild (feral) swine. Brucella spp. under microscopic examination (Public Once within the dog, the bacterium multiplies and Domain: Centers for Disease Control and Prevention) circulates in the blood, moving to and multiplying in body organs. Bacteria can remain within the Who gets it? blood for many years and are easily shed in body Dogs, wild dogs and humans may experience fluids. -
As an Invasive Receptor Cellular Prion Protein on Intestinal M Cells
Cutting Edge: Brucella abortus Exploits a Cellular Prion Protein on Intestinal M Cells as an Invasive Receptor This information is current as Gaku Nakato, Koji Hase, Michio Suzuki, Masanobu Kimura, of September 29, 2021. Manabu Ato, Misaho Hanazato, Minoru Tobiume, Motohiro Horiuchi, Ryuichiro Atarashi, Noriyuki Nishida, Masahisa Watarai, Koichi Imaoka and Hiroshi Ohno J Immunol 2012; 189:1540-1544; Prepublished online 6 July 2012; Downloaded from doi: 10.4049/jimmunol.1103332 http://www.jimmunol.org/content/189/4/1540 References This article cites 30 articles, 8 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/189/4/1540.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 29, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Cutting Edge: Brucella abortus Exploits a Cellular Prion Protein on Intestinal M Cells as an Invasive Receptor ,† ,† ‡ ‡ x Gaku Nakato,* Koji Hase,* Michio{ Suzuki, Masanobu Kimura,‖ Manabu Ato, Misaho Hanazato,*,† Minoru Tobiume, Motohiro Horiuchi, Ryuichiro Atarashi,# Noriyuki Nishida,# Masahisa Watarai,** Koichi Imaoka,‡ and Hiroshi Ohno*,† Brucella abortus is a Gram-negative bacterium causing traffic, a process referred to as transcytosis (2, 3).